KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Liabilities and Shareholders Equity (2016 - 2025)

Lam Research (LRCX) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $21.4 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 7.82% year-over-year to $21.4 billion; the TTM value through Dec 2025 reached $84.6 billion, up 10.74%, while the annual FY2025 figure was $21.3 billion, 13.87% up from the prior year.
  • Liabilities and Shareholders Equity reached $21.4 billion in Q4 2025 per LRCX's latest filing, down from $21.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $21.9 billion in Q3 2025 and bottomed at $15.3 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $18.6 billion, with a median of $18.8 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: increased 20.27% in 2022, then dropped 5.01% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $16.7 billion in 2021, then rose by 15.11% to $19.2 billion in 2022, then dropped by 2.2% to $18.8 billion in 2023, then rose by 5.62% to $19.8 billion in 2024, then increased by 7.82% to $21.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $21.4 billion in Q4 2025, $21.9 billion in Q3 2025, and $21.3 billion in Q2 2025.